321745-04-4

Basic information

• Product Name: 6-(4-Methylpiperazin-1-yl)-1H-indole
• Synonyms: 6-(4-Methylpiperazin-1-yl)-1H-indole
• CAS NO: 321745-04-4
• Molecular Formula: C₁₃H₁₇N₃
• Molecular Weight: 215.29418
• Mol File: 321745-04-4.mol

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 6-(4-Methylpiperazin-1-yl)-1H-indole(CAS DataBase Reference)
• NIST Chemistry Reference: 6-(4-Methylpiperazin-1-yl)-1H-indole(321745-04-4)
• EPA Substance Registry System: 6-(4-Methylpiperazin-1-yl)-1H-indole(321745-04-4)

Safety Data

• Hazardous Substances Data: 321745-04-4(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
6-(4-Methylpiperazin-1-yl)-1H-indole is used as a pharmaceutical intermediate for the development of new drugs. Its unique chemical structure and properties make it a promising candidate for the synthesis of other chemical compounds with potential therapeutic applications.
Used in Medicinal Chemistry Research:
6-(4-Methylpiperazin-1-yl)-1H-indole is used in research to explore its potential biological activity and effects. Its indole and piperazine moieties may contribute to its interactions with biological targets, making it a valuable tool for studying the mechanisms of action of related compounds and their potential applications in medicine.

Upstream product

• 109-01-3 1-methyl-piperazine 
• 52415-29-9 6-bromo-1H-indole 
• 676618-59-0 6-(4-methylpiperazin-1-yl)-1-(triisopropylsilyl)-1H-indole 

Downstream Products

• 209482-07-5 6-(4-methylpiperazin-1-yl)-2,3-dihydro-1H-indole 
• 321745-09-9 1-(4-Fluorophenyl)-6-(4-methylpiperazinyl)-indole 

Relevant articles and documents

P300/CBP HAT INHIBITORS

Provided are compounds of Formula (I): and pharmaceutically acceptable salts and compositions thereof, which are useful for treating a variety of conditions associated with histone acetyltransferase (HAT).

6' SUBSTITUTED COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY

The present disclosure provides compounds having affinity for the 5-HT6 receptor which are of the formula (I): wherein R1—R4 A, B, D, E, and G are as defined herein. The disclosure also relates to methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.

Heterocyclic compounds for the treatment of migraine

Described herein are compounds useful in the treatment of migraine, which have the general formula: wherein: W is a CH group or a N atom; Z is N or C—R4; B and D are selected independently from CH and N, with the proviso that at least one of B and D is CH and with the further proviso that one of B and D can represent N only when W and Z are both other than N; A is a group of Formula II, III or IV, such that group A contains at least 1 N atom; NR7 is either —NH— or —N═;is a single or double bond; X is a N atom, a CH group or a C(OH) group whenis a single bond; or, whenis a double bond, a C atom; Y is an NH, N-alkyl, N-benzyl or CH2group; U and V each represent a N atom or a CH group, with the proviso that both cannot be N; a and b are, independently, 0 or 1; c is an integer from 0 to 3; d is an integer from 1 to 3; e is an integer from 1 to 2; f is an integer from 0 to 3; g is an integer from 3 to 6 and h is an integer from 2 to 3; such that the sum of c and d is at least 2 and the sum of e and f is at least 2; and salts and solvates thereof.